Rani Therapeutics (RANI) Institutional Ownership $1.36 +0.02 (+1.49%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$1.39 +0.03 (+2.21%) As of 03/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Rani Therapeutics (NASDAQ:RANI)CurrentInstitutional OwnershipPercentage30.19%Number ofInstitutional Buyers(last 12 months)11TotalInstitutional Inflows(last 12 months)$1.52MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$934.35K Get RANI Insider Trade Alerts Want to know when executives and insiders are buying or selling Rani Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RANI Institutional Buying and Selling by Quarter Remove Ads Rani Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Two Sigma Advisers LP110,163$151K0.0%N/A0.192% 2/17/2025 Two Sigma Investments LP291,381$399K0.0%N/A0.509% 2/17/2025 Bridgeway Capital Management LLC56,500$77K0.0%-21.0%0.099% 2/13/2025 Insigneo Advisory Services LLC47,500$65K0.0%N/A0.083% 2/12/2025 Takeda Pharmaceutical Co. Ltd.203,190$278K1.0%N/A0.355% 2/11/2025 Virtu Financial LLC45,404$62K0.0%N/A0.079% 2/7/2025 King Luther Capital Management Corp33,000$45K0.0%-59.3%0.058% 1/17/2025 Janney Montgomery Scott LLC27,200$37K0.0%N/A0.047% 11/16/2024 Geode Capital Management LLC172,261$372K0.0%+14.3%0.323% 11/15/2024 United Services Automobile Association302,743$654K0.0%-3.0%0.567% Get the Latest News and Ratings for RANI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rani Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 Stifel Financial Corp269,768$583K0.0%+100.4%0.505% 11/8/2024 King Luther Capital Management Corp81,129$175K0.0%+44.5%0.152% 8/14/2024 Marshall Wace LLP21,247$81K0.0%N/A0.042% 8/9/2024 Renaissance Technologies LLC21,700$82K0.0%-69.1%0.043% 8/7/2024 United Services Automobile Association312,095$1.19M0.0%-35.2%0.619% 5/10/2024 Vanguard Group Inc.685,303$2.13M0.0%+2.5%1.366% 2/14/2024Alpha Square Group S LLC58,946$196K0.2%-32.2%0.118% 8/10/2023 King Luther Capital Management Corp56,129$231K0.0%N/A0.113% 8/4/2023 Choreo LLC19,813$82K0.0%-20.2%0.040% 5/11/2023Icon Wealth Partners LLC12,757$66K0.0%N/A0.026% 5/11/2023 Alphabet Inc.448,492$2.31M0.1%-12.1%0.908% 2/8/2023 Prime Capital Investment Advisors LLC33,502$198K0.0%N/A0.068% 11/18/2022TPB Wealth Advisors48,129$461K0.2%-33.0%0.098% 11/16/2022 Alphabet Inc.714,471$6.85M0.3%N/A1.453% 11/3/2022 Motco48,129$461K0.0%N/A0.098% 10/28/2022 Lafayette Investments Inc.19,893$191K0.1%N/A0.040% 10/17/2022 Canton Hathaway LLC16,200$155K0.1%+88.4%0.033% 10/14/2022 Iowa State Bank18,862$181K0.1%N/A0.038% 8/8/2022 Islay Capital Management LLC9,611$99K0.1%N/A0.020% 8/8/2022Crossvault Capital Management LLC14,285$148K0.1%N/A0.029% 7/29/2022Aspireon Wealth Advisors71,811$742K0.3%N/A0.146% 7/20/2022 Canton Hathaway LLC8,600$89K0.0%N/A0.017% 6/15/2022 Lasry Marc62,828$848K0.4%N/A0.128% 5/17/2022 Lasry Marc62,828$848K0.4%N/A0.128% 5/13/2022 United Services Automobile Association481,300$6.50M0.1%N/A0.979% 2/3/2022 Advisor Group Holdings Inc.21,072$344K0.0%N/A0.043% 1/6/2022 Canton Hathaway LLC5,000$82K0.0%-50.0%0.010% 11/16/2021 Squarepoint Ops LLC50,000$891K0.0%N/A0.102% 11/15/2021 Caas Capital Management LP75,000$1.34M0.0%N/A0.153% 11/10/2021 Goldman Sachs Group Inc.60,649$1.08M0.0%N/A0.124% New “Trump” currency proposed in DC (Ad)According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America. When you see what could happen – I think you’ll be excited.(Data available from 1/1/2016 forward)Remove Ads RANI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RANI shares? During the previous two years, 18 institutional investors and hedge funds held shares of Rani Therapeutics. The most heavily invested institutionals were Alphabet Inc. ($2.31M), Vanguard Group Inc. ($2.13M), United Services Automobile Association ($654K), Stifel Financial Corp ($583K), Two Sigma Investments LP ($399K), Geode Capital Management LLC ($372K), and Takeda Pharmaceutical Co. Ltd. ($278K).Learn more on RANI's institutional investors. What percentage of Rani Therapeutics stock is owned by institutional investors? 30.19% of Rani Therapeutics stock is owned by institutional investors. Learn more on RANI's institutional investor holdings. Which institutional investors have been buying Rani Therapeutics stock? Of the 12 institutional investors that purchased Rani Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Two Sigma Investments LP ($291.38K), Takeda Pharmaceutical Co. Ltd. ($203.19K), Stifel Financial Corp ($135.15K), Two Sigma Advisers LP ($110.16K), King Luther Capital Management Corp ($81.13K), Insigneo Advisory Services LLC ($47.50K), and Virtu Financial LLC ($45.40K). How much institutional buying is happening at Rani Therapeutics? Institutional investors have bought a total of 1,013,602 shares in the last 24 months. This purchase volume represents approximately $1.82M in transactions. Which Rani Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Rani Therapeutics stock in the last 24 months: United Services Automobile Association ($178.56K), Alphabet Inc. ($61.64K), Renaissance Technologies LLC ($48.60K), King Luther Capital Management Corp ($48.13K), Alpha Square Group S LLC ($28K), Bridgeway Capital Management LLC ($15K), and Choreo LLC ($5K). How much institutional selling is happening at Rani Therapeutics? Institutional investors have sold a total of 384,922 shares in the last 24 months. This volume of shares sold represents approximately $1.37M in transactions. Related Companies BNTC Major Shareholders AMLX Major Shareholders ATYR Major Shareholders CMPX Major Shareholders AQST Major Shareholders TECX Major Shareholders ATAI Major Shareholders TERN Major Shareholders PROK Major Shareholders ANNX Major Shareholders This page (NASDAQ:RANI) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rani Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rani Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
